CVS vs JAZZ: fair value comparison
CVS Health Corporation and Jazz Pharmaceuticals plc · Updated 2026-08-31
CVS currently screens as overvalued while JAZZ screens as fairly valued. Within Healthcare, JAZZ currently sits closer to the top of our discount ranking. JAZZ carries the stronger quality grade.
| CVS | JAZZ | |
|---|---|---|
| Verdict | Overvalued | Fairly valued |
| Last price | $93.06 | $251.58 |
| 12-month range | $72.49–$105.37 | $129.66–$251.58 |
| Sector rank | #88 of 113 Healthcare | #84 of 113 Healthcare |
| Quality grade | F | B |
| Momentum grade | — | A |
| Leverage | Moderate | Moderate |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | — | Uptrend |
| DCF cross-check | Overvalued | Fairly Valued |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: CVS fair value analysis · JAZZ fair value analysis